VASOCONSTRICTOR PEPTIDES AND COLD INTOLERANCE IN PATIENTS WITH STABLE ANGINA-PECTORIS

被引:0
作者
DODDS, PA
BELLAMY, CM
MUIRHEAD, RA
PERRY, RA
机构
来源
BRITISH HEART JOURNAL | 1995年 / 73卷 / 01期
关键词
ANGINA PECTORIS; VASOCONSTRICTOR PEPTIDES; COLD INTOLERANCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The exact mechanism that explains the phenomenon of cold intolerance in patients with angina remains controversial. Although the response to the effects of a cold environment has been examined in these patients, their response to cold air inhalation has produced conflicting results. In addition, the possible role of vasoactive peptides in the pathophysiology has not been explored. Objectives-The aims of this study were to examine the response of patients with stable angina to the effects of cold air inhalation during exercise testing, and to investigate the possible role played by the vasoconstrictor peptides endothelin-1 (ET-1) and angiotensin-II (AT-II) in the pathophysiology. Methods-In a randomised order, 12 men with stable angina, whose medication had been stopped, underwent two separate symptom limited treadmill exercise tests. At one visit the patients exercised while breathing room air and at the other visit they exercised while breathing cold air from a specially adapted freezer. Serial peripheral venous blood samples were taken for ET-1 and AT-II estimations during each visit. Results-Cold air inhalation resulted in a significant reduction in the mean time to angina (232.7 (20.4) a v 274.1 (26.9) s, P = 0.04) and the mean total exercise time (299.5 (27.0) s v 350.3 (23.9) s, P = 0.008), but no significant change in the time to 1 mm ST depression (223.3 (29.0) s v 241.3 (29.2) s, P = 0.25). There was no significant difference between the rate-pressure products at the onset of angina (P = 0.13) and the time to 1 mm ST depression (P = 0.85), but at peak exercise the rate-pressure product was significantly lower inpatients breathing cold air as opposed to room air (P = 0.049). There was an equivalent significant decrease in ET-1 concentrations at peak exercise compared with that at rest at both visits (room air 5.0 (0.7) pmol/l v 4.3 (0.7) pmol/l, P = 0.03; cold air 4.4 (0.6) pmol/l v 3.8 (0.5) pmol/l, P = 0.02). There was a significant increase in AT-II concentrations 10 min after peak exercise in patients breathing roam air (39.2 (6.1) pmol/l v 32.1 (4.8) pmol/l, P = 0.01) which was not repeated during cold air inhalation (36.6 (3.4) pmol/l v 28.3 (3.4) pmol/l, P = 0.07). Conclusions-Cold air inhalation in patients with stable angina results in an earlier onset of angina and a reduction in exercise capacity. Both peripheral and central reflex mechanisms appear to contribute to the phenomenon of cold intolerance. Peripheral ET-1 and AT-II do not appear to play a significant role in the pathophysiology.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [41] WHICH DRUG TO CHOOSE FOR STABLE ANGINA-PECTORIS - A COMPARATIVE-STUDY BETWEEN BISOPROLOL AND NITRATES
    VANDEVEN, LLM
    VERMEULEN, A
    TANS, JGM
    TANS, AC
    LIEM, KL
    LAGEWEG, NC
    LIE, KI
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 47 (03) : 217 - 223
  • [42] SELENIUM AND VITAMIN-E CONCENTRATIONS IN PLASMA AND ERYTHROCYTES OF ANGINA-PECTORIS PATIENTS
    SKLODOWSKA, M
    WASOWICZ, W
    GROMADZINSKA, J
    MIROSLAW, W
    STRZELCZYK, M
    MALCZYK, J
    GOCH, JH
    TRACE ELEMENTS IN MEDICINE, 1991, 8 (03): : 113 - 117
  • [43] FREE-RADICAL MARKERS IN PATIENTS WITH ANGINA-PECTORIS AND NORMAL CORONARY ANGIOGRAMS
    BRIDGES, AB
    MCNEILL, GP
    PRINGLE, TH
    NIBLOCK, A
    BELCH, JJF
    CARDIOLOGY, 1993, 82 (01) : 7 - 11
  • [44] CORONARY-ARTERY BYPASS-SURGERY IN PATIENTS WITH ANGINA-PECTORIS AND HYPOTHYROIDISM
    KAWASUJI, M
    SAWA, S
    TSUJIGUCHI, H
    IWA, T
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1991, 5 (05) : 230 - 234
  • [45] HEMODYNAMICS AND EXERCISE TOLERANCE AFTER BISOPROLOL, NIFEDIPINE, AND THEIR COMBINATION IN PATIENTS WITH ANGINA-PECTORIS
    SCHNELLBACHER, K
    BESTEHORN, HP
    ROSKAMM, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 : S201 - S207
  • [46] NICORANDIL SUPPRESSED MYOCARDIAL PURINE METABOLISM DURING EXERCISE IN PATIENTS WITH ANGINA-PECTORIS
    OGINO, K
    OSAKI, S
    NOGUCHI, N
    KITAMURA, H
    OMODANI, H
    KATO, M
    HISATOME, I
    MATSUMOTO, T
    KINUGAWA, T
    MIYAKODA, H
    KOTAKE, H
    MASHIBA, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (3-4) : 189 - 194
  • [47] Layered Plaques and Plaque Vulnerability in Patients With Stable Angina Pectoris
    Niida, Takayuki
    Daisuke, Kinoshita
    Suzuki, Keishi
    Yuki, Haruhito
    Fujimoto, Daichi
    Dey, Damini
    Lee, Hang
    McNulty, Iris
    Ferencik, Maros
    Kakuta, Tsunekazu
    Jang, Ik-kyung
    CIRCULATION, 2023, 148
  • [48] DISTRIBUTION AND SEVERITY OF CORONARY-ARTERY DISEASE IN 500 PATIENTS WITH ANGINA-PECTORIS
    VIEWEG, WVR
    ALPERT, JS
    JOHNSON, AD
    DENNISH, GW
    NELSON, DP
    WARREN, SE
    HAGAN, AD
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1979, 5 (04): : 319 - 330
  • [49] Prognostic implications of renal dysfunction in patients with stable angina pectoris
    Almquist, T.
    Forslund, L.
    Rehnqvist, N.
    Hjemdahl, P.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) : 537 - 544
  • [50] Proteomic analysis of the plasma samples of patients with stable angina pectoris
    Maly, Martin
    Majek, Pavel
    Reicheltova, Zuzana
    Suttnar, Jiri
    Kotlin, Roman
    Hajek, Petr
    Oravec, Milan
    Dyr, Jan E.
    Veselka, Josef
    COR ET VASA, 2012, 54 (01) : E22 - E26